CLINICAL_TRIALS
trial_result
· 2017-03-08
Clinical Trial Update: Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia [Phase 3]
Summary
Phase 3 clinical trial update on sexual function in men taking dutasteride for androgenetic alopecia; trial completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stiefel, a GSK Company | Conditions: Alopecia | Phase 3 | Status: COMPLETED | Results posted: 2017-03-08